115 related articles for article (PubMed ID: 23350688)
1. A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.
Baltanás A; Miguel-Carrasco JL; San José G; Cebrián C; Moreno MU; Dotor J; Borrás-Cuesta F; López B; González A; Díez J; Fortuño A; Zalba G
Antioxid Redox Signal; 2013 Nov; 19(14):1607-18. PubMed ID: 23350688
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
Hermida N; López B; González A; Dotor J; Lasarte JJ; Sarobe P; Borrás-Cuesta F; Díez J
Cardiovasc Res; 2009 Feb; 81(3):601-9. PubMed ID: 19019833
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.
Miguel-Carrasco JL; Baltanás A; Cebrián C; Moreno MU; López B; Hermida N; González A; Dotor J; Borrás-Cuesta F; Díez J; Fortuño A; Zalba G
Oxid Med Cell Longev; 2012; 2012():726940. PubMed ID: 22701756
[TBL] [Abstract][Full Text] [Related]
4. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T
Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
[TBL] [Abstract][Full Text] [Related]
6. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
Saha S; Li Y; Lappas G; Anand-Srivastava MB
J Mol Cell Cardiol; 2008 Feb; 44(2):336-44. PubMed ID: 18162186
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
8. Liver growth factor treatment reverses vascular and plasmatic oxidative stress in spontaneously hypertensive rats.
Condezo-Hoyos L; Arribas SM; Abderrahim F; Somoza B; Gil-Ortega M; Díaz-Gil JJ; Conde MV; Susin C; González MC
J Hypertens; 2012 Jun; 30(6):1185-94. PubMed ID: 22525203
[TBL] [Abstract][Full Text] [Related]
9. Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis.
Santiago B; Gutierrez-Cañas I; Dotor J; Palao G; Lasarte JJ; Ruiz J; Prieto J; Borrás-Cuesta F; Pablos JL
J Invest Dermatol; 2005 Sep; 125(3):450-5. PubMed ID: 16117784
[TBL] [Abstract][Full Text] [Related]
10. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
Wong VY; Laping NJ; Nelson AH; Contino LC; Olson BA; Gygielko E; Campbell WG; Barone F; Brooks DP
Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
[TBL] [Abstract][Full Text] [Related]
11. Kidney fibrosis in hypertensive rats: role of oxidative stress.
Zhao W; Chen SS; Chen Y; Ahokas RA; Sun Y
Am J Nephrol; 2008; 28(4):548-54. PubMed ID: 18239381
[TBL] [Abstract][Full Text] [Related]
12. Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats.
Saha S; Li Y; Anand-Srivastava MB
Can J Physiol Pharmacol; 2008 Apr; 86(4):190-8. PubMed ID: 18418428
[TBL] [Abstract][Full Text] [Related]
13. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
14. Fosinopril and losartan regulate klotho gene and nicotinamide adenine dinucleotide phosphate oxidase expression in kidneys of spontaneously hypertensive rats.
Tang R; Zhou QL; Ao X; Peng WS; Veeraragoo P; Tang TF
Kidney Blood Press Res; 2011; 34(5):350-7. PubMed ID: 21646815
[TBL] [Abstract][Full Text] [Related]
15. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress.
Zhang JJ; Bledsoe G; Kato K; Chao L; Chao J
Kidney Int; 2004 Aug; 66(2):722-32. PubMed ID: 15253727
[TBL] [Abstract][Full Text] [Related]
16. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
Xu H; Tao LJ; Sun M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):61-4. PubMed ID: 16137008
[TBL] [Abstract][Full Text] [Related]
17. A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.
Ezquerro IJ; Lasarte JJ; Dotor J; Castilla-Cortázar I; Bustos M; Peñuelas I; Blanco G; Rodríguez C; Lechuga Mdel C; Greenwel P; Rojkind M; Prieto J; Borrás-Cuesta F
Cytokine; 2003 Apr; 22(1-2):12-20. PubMed ID: 12946101
[TBL] [Abstract][Full Text] [Related]
18. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J
PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation.
Zhan CD; Sindhu RK; Vaziri ND
Kidney Int; 2004 Jan; 65(1):219-27. PubMed ID: 14675053
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.
Chen Y; Zhao W; Liu C; Meng W; Zhao T; Bhattacharya SK; Sun Y
Am J Hypertens; 2019 Apr; 32(5):460-467. PubMed ID: 30715105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
